Real-world experience of drug-eluting stents in saphenous vein grafts compared to native coronary arteries: results from the prospective multicenter German DES.DE registry

go back to reference Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, Killip T, Passamani E, Norris R (1994) Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344:563–570PubMedCrossRef Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, Killip T, Passamani E, Norris R (1994) Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344:563–570PubMedCrossRef

go back to reference Izzat MB, West RR, Bryan AJ, Angelini GD (1994) Coronary artery bypass surgery: current practice in the United Kingdom. Br Heart J 71:382–385PubMedCrossRef Izzat MB, West RR, Bryan AJ, Angelini GD (1994) Coronary artery bypass surgery: current practice in the United Kingdom. Br Heart J 71:382–385PubMedCrossRef

go back to reference Kaneko Y, Schlechta B, Steinberger W, Agstner I, Wolner E, Mohl W (2002) The impact of graft selection on outcome of coronary bypass surgery and influence of surgical experience. Heart Views 3:3 Kaneko Y, Schlechta B, Steinberger W, Agstner I, Wolner E, Mohl W (2002) The impact of graft selection on outcome of coronary bypass surgery and influence of surgical experience. Heart Views 3:3

go back to reference Raja SG, Haider Z, Ahmad M, Zaman H (2004) Saphenous vein grafts: to use or not to use? Heart Lung Circ 13:150–156PubMedCrossRef Raja SG, Haider Z, Ahmad M, Zaman H (2004) Saphenous vein grafts: to use or not to use? Heart Lung Circ 13:150–156PubMedCrossRef

go back to reference Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Hermann HC, Hillis LD, Hutter AM Jr, Ltle BW, Marlow RA, Nugent WC, Orszulak TA, American College of Cardiology; American Heart Association (2004) ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110:e340–e437PubMedCrossRef Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Hermann HC, Hillis LD, Hutter AM Jr, Ltle BW, Marlow RA, Nugent WC, Orszulak TA, American College of Cardiology; American Heart Association (2004) ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110:e340–e437PubMedCrossRef

go back to reference Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR (1996) Coronary bypass graft fate and patient outcome: angiographic follow-up of 5, 065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 28:616–626PubMedCrossRef Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR (1996) Coronary bypass graft fate and patient outcome: angiographic follow-up of 5, 065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 28:616–626PubMedCrossRef

go back to reference Weintraub WS, Jones EL, Craver JM, Guyton RA (1994) Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts. Am J Cardiol 73:103–112PubMedCrossRef Weintraub WS, Jones EL, Craver JM, Guyton RA (1994) Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts. Am J Cardiol 73:103–112PubMedCrossRef

go back to reference European Association for Percutaneous Cardiovascular Interventions; Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D; ESC Committee for Practice Guidelines, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Fillippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Verdas PE, Widimsky P; EACTS Clinical Guidelines Committee, Kolh P, Alfieri O, Dunning J, Elia S, Kappetein P, Lockowandt U, Sarris G, Vouhe P, Kearney P, von Segesser L, Agawall S, Aladashvilli A, Alexopoulos D, Antunes MJ, Atalar E, Brutel de la Riviere A, Doganov A, Aha J, Fajadet J, Ferreira R, Garot J, Halcox J, Hasin Y, Janssens S, Kervinen K, Laufer G, Legrand V, Nashef SA, Neumann FJ, Niemela K, Nihoyannopoulos P, Noc M, Piek JJ, Rozenman Y, Sabate M, Starc R, Thielmann M, Wheatley DJ, WIndecker S, Zembala M (2010) Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Hart J 31:2501–2555 European Association for Percutaneous Cardiovascular Interventions; Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D; ESC Committee for Practice Guidelines, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Fillippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Verdas PE, Widimsky P; EACTS Clinical Guidelines Committee, Kolh P, Alfieri O, Dunning J, Elia S, Kappetein P, Lockowandt U, Sarris G, Vouhe P, Kearney P, von Segesser L, Agawall S, Aladashvilli A, Alexopoulos D, Antunes MJ, Atalar E, Brutel de la Riviere A, Doganov A, Aha J, Fajadet J, Ferreira R, Garot J, Halcox J, Hasin Y, Janssens S, Kervinen K, Laufer G, Legrand V, Nashef SA, Neumann FJ, Niemela K, Nihoyannopoulos P, Noc M, Piek JJ, Rozenman Y, Sabate M, Starc R, Thielmann M, Wheatley DJ, WIndecker S, Zembala M (2010) Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Hart J 31:2501–2555

go back to reference Cameron A, Kemp HG, Green GE (1988) Reoperation for coronary artery disease: 10 years of clinical follow-up. Circulation 78:1158–1162 Cameron A, Kemp HG, Green GE (1988) Reoperation for coronary artery disease: 10 years of clinical follow-up. Circulation 78:1158–1162

go back to reference de Jaegere PP, van Domburg RT, Feyter PJ, Ruygrok PN, van der Giessen WJ, van den Brand MJ, Serruys PW (1996) Long-term clinical outcome after stent implantation in saphenous vein grafts. J Am Coll Cardiol 28:89–96PubMedCrossRef de Jaegere PP, van Domburg RT, Feyter PJ, Ruygrok PN, van der Giessen WJ, van den Brand MJ, Serruys PW (1996) Long-term clinical outcome after stent implantation in saphenous vein grafts. J Am Coll Cardiol 28:89–96PubMedCrossRef

go back to reference Savage MP, Douglas JS Jr, Fischman DL, Pepine CJ, King SB 3rd, Werner JA, Bailey SR, Overlie PA, Fenton SH, Brinker JA, Leon MB, Goldberg S (1997) Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenus Vein De Novo Trial Investigators. N Engl J Med 337:740–747PubMedCrossRef Savage MP, Douglas JS Jr, Fischman DL, Pepine CJ, King SB 3rd, Werner JA, Bailey SR, Overlie PA, Fenton SH, Brinker JA, Leon MB, Goldberg S (1997) Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenus Vein De Novo Trial Investigators. N Engl J Med 337:740–747PubMedCrossRef

go back to reference Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE, SIRIUS Investigators (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315–1323PubMedCrossRef Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE, SIRIUS Investigators (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315–1323PubMedCrossRef

go back to reference Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME, TAXUS-IV Investigators (2004) One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV Trial. Circulation 109:1942–1947PubMedCrossRef Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME, TAXUS-IV Investigators (2004) One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV Trial. Circulation 109:1942–1947PubMedCrossRef

go back to reference Akin I, Bufe A, Schneider S, Reinecke H, Eckardt L, Richardt G, Burska D, Senges J, Kuck KH, Nienaber CA (2010) Clinical outcomes in diabetic and non-diabetic patients with drug-eluting stents: results from the first phase of the prospective multicenter German DES.DE registry. Clin Res Cardiol 99:393–400PubMedCrossRef Akin I, Bufe A, Schneider S, Reinecke H, Eckardt L, Richardt G, Burska D, Senges J, Kuck KH, Nienaber CA (2010) Clinical outcomes in diabetic and non-diabetic patients with drug-eluting stents: results from the first phase of the prospective multicenter German DES.DE registry. Clin Res Cardiol 99:393–400PubMedCrossRef

go back to reference Dibra A, Tiroch K, Schulz S, Kelbaek H, Spaulding C, Laarman GJ, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Campo G, Thuesen L, Vink MA, Schalij MJ, Schömig A, Kastrati A (2010) Drug-eluting stent in acute myocardial infarction: updated meta-analysis of randomized trials. Clin Res Cardiol 99:345–357PubMedCrossRef Dibra A, Tiroch K, Schulz S, Kelbaek H, Spaulding C, Laarman GJ, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Campo G, Thuesen L, Vink MA, Schalij MJ, Schömig A, Kastrati A (2010) Drug-eluting stent in acute myocardial infarction: updated meta-analysis of randomized trials. Clin Res Cardiol 99:345–357PubMedCrossRef

go back to reference Hoffmann R, Klinker H, Adamu Ul Kelm M, Blindt R (2009) The risk of definite stent thrombosis is increased after “off-label” stent implantation irrespective of drug-eluting stent or bare-metal stent use. Clin Res Cardiol 98(9):549–554PubMedCrossRef Hoffmann R, Klinker H, Adamu Ul Kelm M, Blindt R (2009) The risk of definite stent thrombosis is increased after “off-label” stent implantation irrespective of drug-eluting stent or bare-metal stent use. Clin Res Cardiol 98(9):549–554PubMedCrossRef

go back to reference Bauer T, Nienaber CA, Akin I, Kuck KH, Hochadel M, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Zanh R, for the DES.DE Study Group (2011) Comparison between on-label versus off-label use of drug-eluting coronary stents in clinical practice: results from the German DES.DE registry. Clin Res Cardiol 100:701–709PubMedCrossRef Bauer T, Nienaber CA, Akin I, Kuck KH, Hochadel M, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Zanh R, for the DES.DE Study Group (2011) Comparison between on-label versus off-label use of drug-eluting coronary stents in clinical practice: results from the German DES.DE registry. Clin Res Cardiol 100:701–709PubMedCrossRef

go back to reference Zahn R, Hamm CW, Schneider S, Zeymer U, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Nienaber CA, Pfannebecker J, Senges J, German Cypher Stent Registry (2007) The sirolimus-eluting coronary stent in daily practice in Germany: trends in indications over the years: results from the prospective multicenter German Cypher Stent Registry. Clin Res Cardiol 96(8):548–556PubMedCrossRef Zahn R, Hamm CW, Schneider S, Zeymer U, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Nienaber CA, Pfannebecker J, Senges J, German Cypher Stent Registry (2007) The sirolimus-eluting coronary stent in daily practice in Germany: trends in indications over the years: results from the prospective multicenter German Cypher Stent Registry. Clin Res Cardiol 96(8):548–556PubMedCrossRef

go back to reference Nienaber CA, Akin I, Schneider S, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Kuck KH, DES.DE Study Group (2009) Clinical outcome after sirolimus-eluting, paclitaxel-eluting, and bare-metal stents (from the first phase of prospective multicenter German DES.DE registry. Am J Cardiol 104:1362–1369PubMedCrossRef Nienaber CA, Akin I, Schneider S, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Kuck KH, DES.DE Study Group (2009) Clinical outcome after sirolimus-eluting, paclitaxel-eluting, and bare-metal stents (from the first phase of prospective multicenter German DES.DE registry. Am J Cardiol 104:1362–1369PubMedCrossRef

go back to reference Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C, Jørgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W, Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology (2005) Guidelines for Percutaneous Coronary Intervention: the task force for percutaneous coronary interventions of the European society of cardiology. Eur Heart J 26:804–847PubMedCrossRef Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C, Jørgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W, Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology (2005) Guidelines for Percutaneous Coronary Intervention: the task force for percutaneous coronary interventions of the European society of cardiology. Eur Heart J 26:804–847PubMedCrossRef

go back to reference Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van ES GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, Academic Research Consortium (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344–2351PubMedCrossRef Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van ES GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, Academic Research Consortium (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344–2351PubMedCrossRef

go back to reference Keeley EC, Grines CL (1998) Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases. J Am Coll Cardiol 32:1861–1865PubMedCrossRef Keeley EC, Grines CL (1998) Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases. J Am Coll Cardiol 32:1861–1865PubMedCrossRef

go back to reference Mauri L, Cox D, Hermiller J, Massaro J, Wahr J, Tay SW, Jonas M, Popma JJ, Wahr D, Rogers C (2007) The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Praxis Embolic Protection System: A randomized prospective, multicenter clinical trial. J Am Coll Cardiol 50:1442–1449PubMedCrossRef Mauri L, Cox D, Hermiller J, Massaro J, Wahr J, Tay SW, Jonas M, Popma JJ, Wahr D, Rogers C (2007) The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Praxis Embolic Protection System: A randomized prospective, multicenter clinical trial. J Am Coll Cardiol 50:1442–1449PubMedCrossRef

go back to reference Brilakis ES, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Haagen D, Saeed B, Gadiparthi C, Bissett JK, Sachdeva R, Vourris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Baerjee S (2009) A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous graft lesions. The SOS (Stenting Of Saphenous Vein Grafts) Trial. J Am Coll Cardiol 53:919–928PubMedCrossRef Brilakis ES, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Haagen D, Saeed B, Gadiparthi C, Bissett JK, Sachdeva R, Vourris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Baerjee S (2009) A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous graft lesions. The SOS (Stenting Of Saphenous Vein Grafts) Trial. J Am Coll Cardiol 53:919–928PubMedCrossRef

go back to reference Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Bruining N, Van den Branden F, Van Langenhove G (2006) Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. J Am Coll Cardiol 48:2423–2431PubMedCrossRef Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Bruining N, Van den Branden F, Van Langenhove G (2006) Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. J Am Coll Cardiol 48:2423–2431PubMedCrossRef

go back to reference Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Van den Branden F, Van Langenhove G, DELAYED RRISC (Death and Events at Long-term follow-up AnalYsis: Extended Duration of the Reduction of Restenosis In Saphenous vein grafts with Cypher stent) Investigators (2007) Increased late mortality after sirolimus-eluting sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC trial. J Am Coll Cardiol 50:261–267PubMedCrossRef Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Van den Branden F, Van Langenhove G, DELAYED RRISC (Death and Events at Long-term follow-up AnalYsis: Extended Duration of the Reduction of Restenosis In Saphenous vein grafts with Cypher stent) Investigators (2007) Increased late mortality after sirolimus-eluting sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC trial. J Am Coll Cardiol 50:261–267PubMedCrossRef

go back to reference Hoffmann R, Hamm C, Nienaber CA, Levenson B, Bonzel T, Sabin G, Senges J, Zahn R, Tebbe U, Pfannebecker T, Richardt HG, Schneider S, Kelm M, for the German Cypher Registry (2007) Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with higher clinical follow-up event rates compared with treatment of native vessels. Coron Artery Dis 18:559–564PubMedCrossRef Hoffmann R, Hamm C, Nienaber CA, Levenson B, Bonzel T, Sabin G, Senges J, Zahn R, Tebbe U, Pfannebecker T, Richardt HG, Schneider S, Kelm M, for the German Cypher Registry (2007) Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with higher clinical follow-up event rates compared with treatment of native vessels. Coron Artery Dis 18:559–564PubMedCrossRef

go back to reference Vignali L, Saia F, Manari A, Santarelli A, Rubboli A, Varani E, Piovaccari G, Menozzi A, Percoco G, Benassi A, Rusticali G, Marzaroli P, Guastaroba P, Grilli R, Maresta A, Marzocchi A (2008) Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emillial-Romagna Registry). Am J Cardiol 101:947–952PubMedCrossRef Vignali L, Saia F, Manari A, Santarelli A, Rubboli A, Varani E, Piovaccari G, Menozzi A, Percoco G, Benassi A, Rusticali G, Marzaroli P, Guastaroba P, Grilli R, Maresta A, Marzocchi A (2008) Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emillial-Romagna Registry). Am J Cardiol 101:947–952PubMedCrossRef

go back to reference Brodie BR, VerSteeg DS, Brodie MM, Hansen C, Richter SJ, Stuckey TD, Gupta N, Pulsipher M, Downey W (2005) Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion. Catheter Cardiovasc Interv 65:504–509PubMedCrossRef Brodie BR, VerSteeg DS, Brodie MM, Hansen C, Richter SJ, Stuckey TD, Gupta N, Pulsipher M, Downey W (2005) Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion. Catheter Cardiovasc Interv 65:504–509PubMedCrossRef

go back to reference Lins M, Heuer M, Braun P, Franz N, Simon R, FIRST Trial Investigators (2007) Distal embolic protection during percutaneous intervention of aorto-coronary venous bypass grafts: the FIRST Trial. Clin Res Cardiol 96(10):738–742PubMedCrossRef Lins M, Heuer M, Braun P, Franz N, Simon R, FIRST Trial Investigators (2007) Distal embolic protection during percutaneous intervention of aorto-coronary venous bypass grafts: the FIRST Trial. Clin Res Cardiol 96(10):738–742PubMedCrossRef

go back to reference Kalan JM, Roberts WC (1990) Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than 1 year: necropsy analysis of 53 patients, 123 saphenous veins, and 1865 five-millimeter segments. Am Heart J 119:1164–1184PubMedCrossRef Kalan JM, Roberts WC (1990) Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than 1 year: necropsy analysis of 53 patients, 123 saphenous veins, and 1865 five-millimeter segments. Am Heart J 119:1164–1184PubMedCrossRef

go back to reference Mathew V, Berger PB, Lennon RJ, Gersh BJ, Holmes DR Jr (2000) Comparison of percutaneous interventions for unstable angina pectoris in patients with and without previous coronary artery bypass grafting. Am J Cardiol 86:931–937PubMedCrossRef Mathew V, Berger PB, Lennon RJ, Gersh BJ, Holmes DR Jr (2000) Comparison of percutaneous interventions for unstable angina pectoris in patients with and without previous coronary artery bypass grafting. Am J Cardiol 86:931–937PubMedCrossRef